Key result
Magnet application induces asynchronous pacing in pacemakers and suspends tachyarrhythmia therapies in ICDs.
Why the study?
Contemporary cardiac implantable electronic device magnet responses vary across manufacturers, device types, programming states, battery status, MRI modes, telemetry sessions, and sensor technologies, and misunderstanding this behavior can cause inappropriate pacing or unintended loss of defibrillator protection.
Safe clinical use of magnets on contemporary CIEDs requires device identification, awareness of manufacturer-specific exceptions, continuous monitoring, and post-event interrogation to prevent inappropriate pacing or unintended loss of defibrillator protection.
Clinicians must verify manufacturer-specific magnet responses before CIED procedures; leaves open standardization of periprocedural protocols.
UNSTRUCTURED ABSTRACT Magnet application remains a rapid, widely available method to modify cardiac implantable electronic device (CIED) behavior when programmers are not immediately accessible. However, contemporary magnet responses vary across manufacturers, device types, programming states, battery status, MRI modes, telemetry sessions, and sensor technologies. This review summarizes clinically relevant magnet responses in pacemakers, cardiac resynchronization systems, implantable cardioverter-defibrillators (ICDs), and subcutaneous ICDs. In pacing systems, magnet placement usually induces asynchronous pacing at a manufacturer- and battery-dependent rate, although programmable options may allow electrogram storage or no response. In ICDs, magnet application generally suspends tachyarrhythmia therapies without affecting bradycardia pacing; effects on arrhythmia detection vary by manufacturer and device configuration (e.g. MRI protection modes, telemetry, or advanced battery depletion). Safe use requires device identification, awareness of manufacturer-specific exceptions, continuous monitoring, and post-event interrogation when clinically indicated, because misunderstanding magnet behavior may cause inappropriate pacing or unintended loss of defibrillator protection.
No takes yet. Share an insight, caveat, or question.
Vazirani et al. (2026) conducted a review in Cardiac implantable electronic devices (pacemakers, cardiac resynchronization systems, ICDs, and subcutaneous ICDs). Magnet application was evaluated. Magnet application typically induces asynchronous pacing in pacemakers and suspends tachyarrhythmia therapies in ICDs, though responses vary by manufacturer and device status.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: